Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global cancer screening market is expected to grow in the forecast period of 2024-2032 at a CAGR of 9%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The cancer screening industry is being aided by the surging cancer cases across the world. The development of superior imaging to identify the cancerous tissues of different cancer types is also propelling the market growth. As cancer is one of the leading causes of death worldwide, the demand for early detection and cure of the chronic disease is rising. Screenings are increasingly used to detect cancers and to reduce the death rates from the illness. The Asia Pacific region is expected to witness significant growth due to the rising cancer cases attributed to unhealthy lifestyles and the rising consumption of tobaccos and other carcinogenic products. Moreover, the increasing penetration of technological advancements and the improving healthcare infrastructure, along with the rising awareness of various chronic diseases in the emerging economies, such as India, China, Indonesia, and Brazil, among others, are lubricating the market growth.
Geographically, North America holds a significant share of the market due to the surging cancer cases in the country as well as increasing research and development (R&D) to diagnose and treat cancer effectively. Moreover, the advancement of biotechnology and the presence of global players in the region are further fuelling the market growth. The Control of Centre of Diseases and Prevention (CDC) of the United States offers various programs, such as National Breast and Cervical Early Cancer Detection Program (NBCCEDP), through which cost-effective screening is offered to the patients. Such initiatives are lubricating the industry growth.
Cancer screening is a test that can aid in detecting cancer at an early stage before symptoms appear. It decreases the chance of the cancerous cells to grow abnormally and reduces the mortality rates of the person. Each type of cancer has its screening test, which can aid in detecting cancer in its early stages.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the cancer types, the industry is divided into:
The major techniques of cancer screening are:
The market can be broadly categorised on the basis of stage by:
On the basis of gender, the market is segmented into:
The EMR report looks into the regional markets of cancer screening like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Screening can detect cancer at an early stage, due to which the treatment can be started in the early stages, which can reduce the risk of death. The rising cases of death due to cancer is driving the market growth. Increasing research and development (R&D) to create effective treatments and early diagnosis of cancer is further propelling the market growth. Innovative technologies such as positron emission mammography, spectroscopy-enhanced colonoscopy, and hyperpolarisation MRI, among others, are increasing the efficiency of screening, consequently aiding the industry growth. Moreover, further research and innovations in the field of leukaemia and ovarian cancer, which are currently difficult to screen, are further expected to propel the industry growth in the forecast period.
The use of artificial intelligence (AI) to improve the accuracy, the speed of diagnosis, and reduce health disparity in a low-resource setting is driving the market growth. As artificial intelligence can aid clinical decision making, identify specific gene mutations, and improve MRI guided biopsy, they are used in research by various organisations, such as National Cancer Institute, which is providing further impetus to the market growth. Moreover, the use of advanced technology such as real-time data analysis, computation and digital pathology, and molecular diagnostics to enable pattern recognition in population data to predict treatment response, survival, and the likelihood of recurrence are further anticipated to aid the market growth.
The report presents a detailed analysis of the following key players in the global cancer screening market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Technique |
|
Breakup by Stage |
|
Breakup by Gender |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
The cancer screening market is projected to grow at a CAGR of 9% between 2024 and 2032.
The industry is being aided by the surge of cancer cases worldwide and the increasing efforts and favourable government initiatives to prevent cancer by diagnosing them at early stages.
The industry is driven by the technological advancements, increasing research and development (R&D) to prevent and detect cancer, and the use of advanced technology such as artificial intelligence (AI) and real-time data analytics to detect cancer efficiently.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.
The major cancer types of cancer screening in the industry are lung cancer, blood cancer, bone cancer, gall bladder cancer, testicular cancer, thyroid cancer, and breast cancer, among others.
The significant techniques in the market are imaging techniques, endoscopy, biopsy and cytology tests, and genomic and molecular tests.
The leading stages of cancer screening in the market are TNM stages, stages 0, 1, 2, 3, 4, and prognostic factors, among others.
The dominant genders in the industry are men and women.
The major players in the industry are DiaSorin S.p.A., Epigenomics AG, Techlab, Inc., Positive Biosciences Limited, MedGenome Labs Ltd, and 20/20 GeneSystems, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124